Amgen acquired worldwide rights to psoriasis drug Otezla (apremilast) For $13.4 Billion
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaᆴ (apremilast), the only oral, non-biologic treatment for psoriasis…
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaᆴ (apremilast), the only oral, non-biologic treatment for psoriasis…
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ᅠleaseᅠ…
On Aug. 22, 2019, Chinook Therapeutics announced a $65 million Series A financing to discover and develop precision…
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
On Jun. 18, 2019, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
On Apr. 25, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
On Mar. 13, 2019, Nature published a call for a global moratorium on heritable human genome editing signed by…
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
On Feb. 25, 2019, the Tyrosinemia Society (TS, Inc.) was founded by Dr. Elizabeth Barnby, a researcher and…
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
On Dec. 5, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Oct. 25, 2018, the American Dental Association adopted a policy to support the use and administration of…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…
On Oct. 5, 2018, the rationale around the Microbiome Vault initiative was published in Science. The initiative was…
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
On Sept. 11, 2018, the NSF launched the 2026 Idea Machine: A mechanism to set the stage for…
On Sept. 11, 2018, the U.S. Food and Drug Administration (FDA) had announced that it had received 510k…